Literature DB >> 21281804

IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion.

David Rafei1, Ralf Müller, Norito Ishii, Maria Llamazares, Takashi Hashimoto, Michael Hertl, Rüdiger Eming.   

Abstract

Pemphigus is considered an autoimmune bullous skin disorder associated with IgG against the desmosomal components, desmoglein 3 (Dsg3) and desmoglein 1 (Dsg1). This concept is supported by the in vitro and in vivo pathogenicity of anti-Dsg3/Dsg1 IgG and the mucosal blistering phenotype of mice with a genetic deficiency of Dsg3. Mice deficient for another desmosomal adhesion molecule, desmocollin 3 (Dsc3), show a similar pemphigus phenotype, and we investigated the pathogenicity of Dsc3-reactive IgG autoantibodies that were identified previously in a subset of patients with atypical pemphigus. We here demonstrate that IgG against Dsc3 causes loss of adhesion of epidermal keratinocytes. Specifically, IgG against Dsc3 was purified from Dsc3-reactive pemphigus sera by affinity column chromatography using recombinant human Dsc3. Affinity purified IgG was functionally active and did not only react with recombinant Dsc3 but also with epidermis and cultured human keratinocytes. Moreover, Dsc3-reactive IgG induced loss of adhesion of epidermal keratinocytes in a dispase-based keratinocyte dissociation assay that was reversed on pre-adsorption with human Dsc3 but not Dsg3. These findings demonstrate that IgG autoantibodies against an additional component of the desmosomes, Dsc3, induce loss of keratinocyte adhesion and thus may contribute to blister formation in pemphigus.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281804      PMCID: PMC3069870          DOI: 10.1016/j.ajpath.2010.10.016

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

Review 1.  Immunopathology of paraneoplastic pemphigus.

Authors:  T Hashimoto
Journal:  Clin Dermatol       Date:  2001 Nov-Dec       Impact factor: 3.541

2.  Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion.

Authors:  M Amagai; V Klaus-Kovtun; J R Stanley
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

3.  Demonstration of antibodies to bovine desmocollin isoforms in certain pemphigus sera.

Authors:  M Dmochowski; T Hashimoto; M A Chidgey; K K Yue; R W Wilkinson; T Nishikawa; D R Garrod
Journal:  Br J Dermatol       Date:  1995-10       Impact factor: 9.302

Review 4.  Unusual acantholytic bullous dermatosis associated with neoplasia and IgG and IgA antibodies against bovine desmocollins I and II.

Authors:  T P Chorzelski; T Hashimoto; T Nishikawa; T Ebihara; M Dmochowski; M Ismail; S Jabłońska
Journal:  J Am Acad Dermatol       Date:  1994-08       Impact factor: 11.527

5.  A case of pemphigus vulgaris showing reactivity with pemphigus antigens (Dsg1 and Dsg3) and desmocollins.

Authors:  T Hashimoto; M Amagai; K Watanabe; M Dmochowski; M A Chidgey; K K Yue; D R Garrod; T Nishikawa
Journal:  J Invest Dermatol       Date:  1995-04       Impact factor: 8.551

6.  The distribution of IgA pemphigus antigen in human skin and the role of IgA anti-cell surface antibodies in the induction of intraepidermal acantholysis.

Authors:  N Supapannachart; D F Mutasim
Journal:  Arch Dermatol       Date:  1993-05

7.  Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.

Authors:  M Amagai; T Hashimoto; N Shimizu; T Nishikawa
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  The detection of IgG and IgA autoantibodies to desmocollins 1-3 by enzyme-linked immunosorbent assays using baculovirus-expressed proteins, in atypical pemphigus but not in typical pemphigus.

Authors:  Y Hisamatsu; M Amagai; D R Garrod; T Kanzaki; T Hashimoto
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

Review 9.  Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype.

Authors:  S Lebeau; R Müller; I Masouyé; M Hertl; L Borradori
Journal:  Clin Exp Dermatol       Date:  2009-10-23       Impact factor: 3.470

10.  Pemphigus herpetiformis with IgA and IgG antibodies to desmoglein 1 and IgG antibodies to desmocollin 3.

Authors:  A Kozlowska; T Hashimoto; M Jarzabek-Chorzelska; A Amagai; Y Nagata; Z Strasz; S Jablonska
Journal:  J Am Acad Dermatol       Date:  2003-01       Impact factor: 11.527

View more
  23 in total

Review 1.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 2.  Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

Authors:  Christoph M Hammers; John R Stanley
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

Review 3.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

4.  From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases.

Authors:  Ralf J Ludwig; Luca Borradori; Luis A Diaz; Takashi Hashimoto; Michael Hertl; Saleh M Ibrahim; Marcel F Jonkman; Yasuo Kitajima; Dédée F Murrell; Enno Schmidt; Hiroshi Shimizu; John R Stanley; David T Woodley; Detlef Zillikens
Journal:  J Invest Dermatol       Date:  2014-09       Impact factor: 8.551

Review 5.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

6.  Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering.

Authors:  Volker Spindler; Vera Rötzer; Carina Dehner; Bettina Kempf; Martin Gliem; Mariya Radeva; Eva Hartlieb; Gregory S Harms; Enno Schmidt; Jens Waschke
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

7.  Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.

Authors:  Alex Chernyavsky; Kyle T Amber; Arianna F Agnoletti; Candice Wang; Sergei A Grando
Journal:  J Biol Chem       Date:  2019-01-28       Impact factor: 5.157

Review 8.  Desmosomes in acquired disease.

Authors:  Sara N Stahley; Andrew P Kowalczyk
Journal:  Cell Tissue Res       Date:  2015-03-21       Impact factor: 5.249

Review 9.  Integrating animal models and in vitro tissue models to elucidate the role of desmosomal proteins in diseases.

Authors:  Maranke I Koster; Jason Dinella; Jiangli Chen; Charlene O'Shea; Peter J Koch
Journal:  Cell Commun Adhes       Date:  2014-02

Review 10.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.